Tolerating subretinal fluid in neovascular age-related macular degeneration treated with ranibizumab using a treat-and-extend regimen: FLUID study 24-month results

FLUID Investigators

Research output: Contribution to journalArticlepeer-review

132 Citations (Web of Science)

Fingerprint

Dive into the research topics of 'Tolerating subretinal fluid in neovascular age-related macular degeneration treated with ranibizumab using a treat-and-extend regimen: FLUID study 24-month results'. Together they form a unique fingerprint.

Medicine & Life Sciences